The EU Pharmacovigilance Risk Assessment Committee (PRAC)

Updated 15 July 2014

Each month, safety surveillance of medicines is discussed in the EU by the Pharmacovigilance Risk Assessment Committee (PRAC).

PRAC belongs under the London-based European Medicines Agency (EMA) and is made up of representatives from every EU Member State.

The main topics discussed and conclusions drawn at the PRAC meetings are posted on the EMA website after every meeting.

Link to PRAC: Agendas, minutes and highlights


Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.